Development of indole-3-propionic acid (OXIGON™) for Alzheimer's disease

P. E. Bendheim, B. Poeggeler, E. Neria, V. Ziv, M. A. Pappolla, D. G. Chain

Research output: Contribution to journalArticle

73 Scopus citations

Abstract

The accumulation of amyloid-beta and concomitant oxidative stress are major pathogenic events in Alzheimer's disease. Indole-3-propionic acid (IPA, OXIGON™) is a potent anti-oxidant devoid of pro-oxidant activity. IPA has been demonstrated to be an inhibitor of beta-amyloid fibril formation and to be a potent neuroprotectant against a variety of oxidotoxins. This review will summarize the known properties of IPA and outline the rationale behind its selection as a potential disease-modifying therapy for Alzheimer's disease.

Original languageEnglish (US)
Pages (from-to)213-217
Number of pages5
JournalJournal of Molecular Neuroscience
Volume19
Issue number1-2
DOIs
StatePublished - Jan 1 2002
Externally publishedYes

    Fingerprint

Keywords

  • Alzheimer's disease
  • Beta-amyloid
  • Indole-3-propionic acid
  • Oxidative stress

ASJC Scopus subject areas

  • Cellular and Molecular Neuroscience

Cite this